RYMNX | SGGDX | RYMNX / SGGDX | |
Total Expense Ratio | 1.55 | 1.16 | 134% |
Annual Report Gross Expense Ratio | 1.58 | 1.16 | 136% |
Fund Existence | 21 years | 32 years | - |
Gain YTD | 49.162 | 50.593 | 97% |
Front Load | 5% | 5% | 95% |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 115M | 3.74B | 3% |
Annual Yield % from dividends | 0.00 | 3.67 | - |
Returns for 1 year | 44.51 | 53.26 | 84% |
Returns for 3 years | 44.32 | 73.34 | 60% |
Returns for 5 years | 50.34 | 82.12 | 61% |
Returns for 10 years | 129.47 | 186.14 | 70% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GF | 12.01 | 0.11 | +0.92% |
NEW Germany Fund | |||
BBC | 19.76 | 0.18 | +0.91% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
FITE | 71.67 | 0.63 | +0.88% |
SPDR® S&P Kensho Future Security ETF | |||
NMCO | 10.56 | 0.06 | +0.57% |
Nuveen Municipal Credit Opportunities Fund | |||
DISV | 32.43 | -0.02 | -0.06% |
Dimensional International Sm Cp Val ETF |